Shamir Genomic Center (SGC)


Shamir Genomic Center (SGC) at Shamir Medical Center, headed by Dr. Nir Rainy (Ph.D) was established to provide cutting edge diagnostics services to our patients. Our highly experienced team and state of the art equipment provide a rapid, in-depth sequencing of any sample type. We tailor a solution to fit any research need and employ advanced automated protocols for sample processing and library preparation. Our sequencing technology is based on Illumina® short reads technology and we develop reliable and innovative bioinformatics applications for each project.

SGC and COVID-19

Since its emergence in China, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide. In the past few months, mutations that have emerged independently in many global strains (such as those from the UK, South Africa, and Brazil), affected the infectivity of the variant, its resistance to vaccines and its capability of reinfection, in addition to potential increase in the severity of disease. Future public health policy and efficient pandemic response will require rapid identification on introduction into communities and knowledge of the presence of these variants in the local population. According to recent publications, many countries lack these capabilities, are struggling with rising case of COVID-19 patients and are prone to repeated quarantines, lockdowns serious economic repercussions.

Shamir Genomic Center (SGC) at Shamir Medical Center, headed by Dr. Nir Rainy, is a member of the Israeli national sequencing consortium and plays a major role in identifying and monitoring SARS‑CoV‑2 variants in Israel. Thanks to its high throughput capabilities, our center completed more than 20,000 positive SARS‑CoV‑2 samples in 2021.